Successful Use of Low Dose r-Hirudin (Refludan®) for Recurrent Dialysis Catheter Thrombosis in a Patient with Heparin Induced Thrombocytopenia

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Thromb Haemost 1999; 82(03): 1205-1206
DOI: 10.1055/s-0037-1614360

Letters to the Editor

Schattauer GmbH

Successful Use of Low Dose r-Hirudin (Refludan^®) for Recurrent Dialysis Catheter Thrombosis in a Patient with Heparin Induced Thrombocytopenia

Viren B. Patel

¹From The University of Nevada School of Medicine, Reno, NV

,

Joseph Snyder

²The University Medical Center, Las Vegas, NV

,

Rinah I. Shopnick

³The Hemophilia and Thrombosis Center of Nevada, Las Vegas, USA

Further Information

Received 26 February 1999

Accepted 02 May 1999

Publication Date:
09 December 2017 (online)

References
1 Hoechst Marion Roussel. Package literature for Refludan^® . March 1998

PubMed Google Scholar
2 Vanholder R, Camez A, Veys N, Van Loo A, Dhond AM, Ringoir S. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients. Thromb Haemost 1997; 77 (04) 650-5.

Article in Thieme Connect PubMed Google Scholar